Drugs / Xeno V+
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04225247 Comparator | Mar → Oct 2018 | dentin sensitivity | Dow University of Health Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xeno V+ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04225247 ↗ |
| Modality | Other / unclassified | “Xeno V+ (by Dentsply) is a seventh generation bonding agents used as desensitizers in the present study.” NCT04225247 ↗ |
| Route | Topical | “applied on the affected surface of the group-II participants.” NCT04225247 ↗ |